The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Blog I

Alexza Pharmaceuticals Partnership Continues with Quality Assurance Leadership Search

August 4, 2021
Alexza Pharmaceuticals continues to partner with The Chase Group to secure a Senior Director/Head, Quality Assurance. The Chase Group is currently seeking quality assurance professionals… Continue Reading →

Atsena Therapeutics Retains The Chase Group to Identify Head of Regulatory

July 28, 2021
Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company… Continue Reading →

Ventria Continues Partnership with The Chase Group to Find Agronomy Operations Leader

July 27, 2021
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an… Continue Reading →

The Chase Group Secures VP, Head of Regulatory Affairs for Checkmate Pharmaceuticals

June 23, 2021
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate… Continue Reading →

The Most Difficult Executive Searches – Completed Faster and Easier

June 8, 2021
Dr. Tahamtan Ahmadi, Executive Vice President and Chief Medical Officer at Genmab A/S is responsible for the overall research organization and strategic drug development functions. Specialists with deep drug development experience in oncology are critical to Genmab’s development efforts – and are among the most difficult to identify, entice, and attract. Dr. Ahmadi works with The Chase Group on his key executive searches because of the firm’s ability to match the vision and needs of Genmab with the motivations, strengths, and goals of the best candidates. Continue Reading →

The Chase Group Secures Teng Jin Ong for Genmab

May 28, 2021
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the… Continue Reading →

Building the Next Generation of RNA Medicines – With Exceptional Talent

May 22, 2021
Arcturus Therapeutics, an RNA medicines company engaged in the development of therapeutics for rare diseases and vaccines – including one in clinical trials for COVID-19 – is growing quickly and adding key executives in clinical development and drug safety. To find this elite group of clinicians, the company relies on The Chase Group and its network of carefully curated candidates, expert screening skills, and comprehensive project management that leaves nothing to chance. Continue Reading →

Ventria Bioscience Cuts to The Chase!

May 6, 2021
Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of… Continue Reading →

Genmab Continues Partnership with The Chase Group as their Drug Safety Leadership Team Grows

April 20, 2021
Over the past three years, Genmab has retained The Chase Group to execute four Director, Drug Safety and Pharmacovigilance (PV) physician searches that all concluded… Continue Reading →

Growth is on the Horizon as Biologics Consulting continues Partnership with The Chase Group to Expand Leadership Team

April 8, 2021
The Chase Group is pleased to announce their continued partnership with Biologics Consulting after being retained to execute a search for a Business Development Lead…. Continue Reading →
© Copyright 1993-2021 The Chase Group; All Rights Reserved.